Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incannex Healthcare (IXHL) Gains from Investment Securities: 2024-2025

Historic Gains from Investment Securities for Incannex Healthcare (IXHL) over the last 2 years, with Jun 2025 value amounting to $227,508.

  • Incannex Healthcare's Gains from Investment Securities fell 49.72% to $118,173 in Q3 2025 from the same period last year, while for Sep 2025 it was $118,173, marking a year-over-year decrease of 49.72%. This contributed to the annual value of $227,508 for FY2025, which is 3.19% down from last year.
  • According to the latest figures from FY2025, Incannex Healthcare's Gains from Investment Securities is $227,508, which was down 3.19% from $235,008 recorded in FY2024.
  • Incannex Healthcare's 5-year Gains from Investment Securities high stood at $235,008 for FY2024, and its period low was $227,508 during FY2025.
  • For the 2-year period, Incannex Healthcare's Gains from Investment Securities averaged around $231,258, with its median value being $231,258 (2024).
  • Data for Incannex Healthcare's Gains from Investment Securities shows a maximum YoY decreased of 3.19% (in 2025) over the last 5 years.
  • Over the past 2 years, Incannex Healthcare's Gains from Investment Securities (Yearly) stood at $235,008 in 2024, then dropped by 3.19% to $227,508 in 2025.